WallStreetZenWallStreetZen

NASDAQ: BOLT
Bolt Biotherapeutics Inc Stock Forecast, Predictions & Price Target

Analyst price target for BOLT

Based on 1 analyst offering 12 month price targets for Bolt Biotherapeutics Inc.
Min Forecast
$8.00+589.66%
Avg Forecast
$8.00+589.66%
Max Forecast
$8.00+589.66%

Should I buy or sell BOLT stock?

Based on 1 analyst offering ratings for Bolt Biotherapeutics Inc.
Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their BOLT stock forecasts and price targets.

BOLT stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-03-22

1 of 1

BOLT vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
BOLT$1.16$8.00+589.66%Buy
CLNN$0.35$6.00+1,634.10%Strong Buy
QNCX$1.03N/AN/A
INAB$1.04$8.83+749.33%Strong Buy
NKGN$1.98N/AN/A

Bolt Biotherapeutics Stock Forecast FAQ

Is Bolt Biotherapeutics Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: BOLT) stock is to Buy BOLT stock.

Out of 1 analyst, 0 (0%) are recommending BOLT as a Strong Buy, 1 (100%) are recommending BOLT as a Buy, 0 (0%) are recommending BOLT as a Hold, 0 (0%) are recommending BOLT as a Sell, and 0 (0%) are recommending BOLT as a Strong Sell.

If you're new to stock investing, here's how to buy Bolt Biotherapeutics stock.

What is BOLT's Price Target?

According to 1 Wall Street analyst that have issued a 1 year BOLT price target, the average BOLT price target is $8.00, with the highest BOLT stock price forecast at $8.00 and the lowest BOLT stock price forecast at $8.00.

The Wall Street analyst predicted that Bolt Biotherapeutics's share price could reach $8.00 by Mar 22, 2025. The average Bolt Biotherapeutics stock price prediction forecasts a potential upside of 589.66% from the current BOLT share price of $1.16.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.